Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 2;28(11):996-1004.
doi: 10.1093/oncolo/oyad214.

Opioid Risk Mitigation Practices of Interprofessional Oncology Personnel: Results From a Cross-Sectional Survey

Gretchen A McNally  1 , Eric M McLaughlin  2 , Emily Ridgway-Limle  1 , Robin Rosselet  3 , Robert Baiocchi  4
Affiliations

Opioid Risk Mitigation Practices of Interprofessional Oncology Personnel: Results From a Cross-Sectional Survey

Gretchen A McNally et al. Oncologist. .

Abstract

Background: This study explored the risk mitigation practices of multidisciplinary oncology health-care personnel for the nonmedical use of opioids in people with cancer.

Methods: An anonymous, cross-sectional descriptive survey was administered via email to eligible providers over 4 weeks at The Ohio State University's Arthur G. James Cancer Hospital. The survey asked about experiences and knowledge related to opioid use disorders.

Results: The final sample of 773 participants included 42 physicians, 213 advanced practice providers (APPs consisted of advanced practice nurses, physician assistants, and pharmacists), and 518 registered nurses. Approximately 40% of participants responded feeling "not confident" in addressing medication diversion. The most frequent risk reduction measure was "Checking the prescription drug monitoring program" when prescribing controlled medications, reported by physicians (n = 29, 78.4%) and APPs (n = 164, 88.6%).

Conclusion: People with cancer are not exempt from the opioid epidemic and may be at risk for nonmedical opioid use (NMOU) and substance use disorders. Implementing risk reduction strategies with every patient, with a harm reduction versus abstinence focus, minimizes harmful consequences and improves. This study highlights risk mitigation approaches for NMOU, representing an opportunity to improve awareness among oncology health-care providers. Multidisciplinary oncology teams are ideally positioned to navigate patients through complex oncology and health-care journeys.

Keywords: harm reduction; nonmedical use of opioids; oncology health-care personnel; opioid use disorders.

PubMed Disclaimer

Conflict of interest statement

The authors indicated no financial relationships.

Figures

Figure 1.
Figure 1.
Complete survey.
Figure 1.
Figure 1.
Complete survey.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Arthur J, Bruera E.. Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer. Nat Rev Clin Oncol. 2019;16(4):213-226. 10.1038/s41571-018-0143-7. - DOI - PubMed
    1. Magee D, Bachtold S, Brown M, Farquhar-Smith P.. Cancer pain: where are we now?. Pain Manag. 2019;9(1):63-79. 10.2217/pmt-2018-0031. - DOI - PubMed
    1. Sager Z, Childers J.. Navigating challenging conversations about nonmedical opioid use in the context of oncology. Oncologist. 2019;24(10):1299-1304. 10.1634/theoncologist.2019-0277. - DOI - PMC - PubMed
    1. Yusufov M, Braun IM, Pirl WF.. A systematic review of substance use and substance use disorders in patients with cancer. Gen Hosp Psychiatry. 2019;60:128-136. 10.1016/j.genhosppsych.2019.04.016. - DOI - PubMed
    1. Amaram-Davila J, Davis M, Reddy A.. Opioids and cancer mortality. Curr Treat Options Oncol. 2020;21(3):22. 10.1007/s11864-020-0713-7. - DOI - PubMed

Substances